Publication | Open Access

Alzheimer's-associated Aβ oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal

Synaptic TransmissionNeurochemical BiomarkersSynaptic SignalingAltered StructureAlzheimer's DiseaseSynaptic NeuroscienceDegenerative PathologyProtein MisfoldingNeurologyAging-associated DiseaseNeurodegenerationPharmacologyProtective MechanismsSynaptic PlasticityNeurodegenerative DiseasesAlzheimer's-associated Aβ OligomersNeuroscienceLow DosesMedicine